🟢 Capricor Therapeutics is trading 6% up

Capricor Therapeutics is trading at $6.08, up 6.01%, alongside a broader biotech rally; no direct catalyst for the October 27 move was identified.

• The XBI is up 2.18%, and major indices are higher, which may be supporting shares.
• The latest company news found was October 5 HOPE-3 data.
• The November 22 FDA decision on deramiocel remains relevant background, but available evidence does not identify it as the direct catalyst for this session.